Question 1

What is the best GLP-1 program overall?

Accepted Answer

Embody currently ranks first of 50 programs at 9.4 out of 10, with Yucca Health (9.3) and TrimRx (9.2) close behind. The lowest verified price across the whole register is $69 a month. The right pick still depends on your state, your budget and whether you want brand-name or compounded medication — the segments under the ranking break each of those out.

Question 2

Compounded or brand-name — how do I choose?

Accepted Answer

Brand-name medication (Ozempic, Wegovy, Zepbound) is FDA-approved, and it is the default if your insurance covers it or you can pay the manufacturer’s direct-pay rate. Compounded semaglutide is the cash-pay route, and it is where the low monthly prices come from — legal, but not an FDA-approved product, so the pharmacy behind it is the deciding variable. That is exactly what the safety register checks.

Question 3

How fast can I actually start?

Accepted Answer

Telehealth programs typically review an intake within one to three days and ship the same week. Your own physician takes longer, but is the only route to insurance-covered brand-name medication.

Question 4

Can I switch programs later?

Accepted Answer

Yes. Request your records and dose history — a program has to provide them — then complete the new program’s intake. Month-to-month programs make this easiest; a prepaid plan trades that flexibility for the lower monthly price.

Question 5

How much does semaglutide cost per month?

Accepted Answer

It depends entirely on the route: what your insurance covers, the manufacturer’s direct-pay rate, the pharmacy list price, or a cash-pay telehealth program — where the lowest price we have verified is $69 a month. The cost pages put the public acquisition cost beside each one, so a quoted price has something to stand against.

Question 6

Why do programs advertise one price and charge another?

Accepted Answer

The advertised rate is usually a prepaid or first-month rate. Month-to-month rates run higher, and some programs price by dose. We record both numbers with the date and the page they were read from, so a price you cannot reach at the checkout shows up as what it is.

Question 7

Are GLP-1 programs HSA/FSA eligible?

Accepted Answer

Most cash-pay programs are, because the medication is prescribed. Confirm with your plan administrator first — some require a letter of medical necessity.

Question 8

Does insurance cover any of these programs?

Accepted Answer

A few bill insurance; most are cash-pay by design, because coverage for weight management is patchy. If your plan covers brand-name GLP-1s, that usually beats any cash price, so check that first.

Question 9

Is compounded semaglutide safe?

Accepted Answer

It is legal, and a licensed pharmacy can prepare it safely, but it is not an FDA-approved product. Safety rests on the pharmacy: licensure, sterile practice and testing. The register tracks the public record for each one, and an open FDA warning letter removes a program from every recommendation on this site.

Question 10

How do I know a program is legitimate?

Accepted Answer

Four fast tests. A prescription is required. The pharmacy is named and licensed in the United States. The price is plausible against what a pharmacy pays to acquire the drug, which the cost pages publish. And there are no open FDA letters against it.

Question 11

What are the red flags?

Accepted Answer

No prescription required, “research use only” labeling, a price far below every verified program in the register, no named pharmacy, and payment by wire or crypto. Any one of them is disqualifying on its own.

Question 12

Who ranks these programs?

Accepted Answer

Ratings and written verdicts are editorial judgements published by glp1watchdog.com, a sister site under the same ownership. They are not computed from the federal data here; the methodology page explains how each one is carried across. The rating then sets the order of the 50 programs and the verified monthly price breaks the tie, and an open critical safety flag bars a program from every recommendation, whatever it scores.

Question 13

What is the difference between semaglutide and tirzepatide?

Accepted Answer

Both are injectable GLP-1 receptor agonists. Semaglutide (Ozempic, Wegovy) targets GLP-1 alone; tirzepatide (Mounjaro, Zepbound) adds GIP activity and showed greater average weight loss in head-to-head trials. Tirzepatide usually costs more. Which one suits you is a clinical question.

Question 14

What are the common side effects?

Accepted Answer

Nausea, constipation and fatigue are the frequent ones, usually strongest while the dose is going up. Serious risks such as pancreatitis and gallbladder disease are rarer, and are why intake review and clinician follow-up matter. Report severe symptoms to your prescriber immediately.

Question 15

What happens when I stop taking a GLP-1?

Accepted Answer

Appetite returns, and studies show most patients regain a substantial share of the lost weight within a year without continued therapy or lifestyle change. Plan the off-ramp with your clinician before you start, not after.

Question 16

Do I need to diet and exercise too?

Accepted Answer

The trials behind the headline numbers all paired medication with lifestyle support. The medication reduces appetite; it does not build habits. Programs that include coaching exist for exactly this.

Question 17

Who runs this site?

Accepted Answer

Sam Reed, the data lead who built and maintains the pipeline behind it. No licensed clinician reviews these pages yet, and the site says so on every one: a page with no reviewer byline makes no clinical claim. What it publishes is cost and access data, with the source of every figure named.

Question 18

Where does the data come from?

Accepted Answer

Four federal sources. The CMS National Average Drug Acquisition Cost survey for what a pharmacy pays to buy each product — 1,153 price rows across 13 medications. CMS Medicare Part D for 199,389 clinician-drug records behind the prescriber pages. CMS State Drug Utilization for what Medicaid paid by state. The FDA NDC directory and the FDA enforcement records for pack sizes, warning letters and 503B facilities. Program prices are not federal data: each one is read from the program's own site and recorded with the date and the page it was read from.

Question 19

How does this site make money?

Accepted Answer

Some outbound links to programs pay a commission when a reader signs up. You pay the same price either way, every paid link is marked as sponsored, and the affiliate disclosure lists where they appear. Commission buys no rating and no ranking position, and the safety register carries no commercial links at all.

Question 20

Was this site called something else?

Accepted Answer

Yes. It published as glp1foryou.com until 2026, then moved to glp1.health. Same owner, same sources, same method — only the domain changed.

Questions & answers

Choosing a program

Costs & insurance

Safety & legitimacy

The medications

About this site

Answered? Then find your program.